Spire Healthcare Group PLC (SPI) Receives Consensus Rating of “Hold” from Analysts

Spire Healthcare Group PLC (LON:SPI) has been given an average rating of “Hold” by the seven research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is GBX 309.17 ($4.19).

Several research analysts have recently commented on SPI shares. Berenberg Bank raised shares of Spire Healthcare Group to a “buy” rating and raised their price objective for the company from GBX 270 ($3.66) to GBX 310 ($4.20) in a research note on Wednesday, November 29th. Liberum Capital reissued a “hold” rating and issued a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research note on Tuesday, October 10th. Numis Securities reiterated an “add” rating and issued a GBX 341 ($4.62) price target on shares of Spire Healthcare Group in a research note on Monday, October 23rd. Jefferies Group decreased their price target on shares of Spire Healthcare Group from GBX 350 ($4.75) to GBX 259 ($3.51) and set a “hold” rating for the company in a research note on Monday, September 25th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 339 ($4.60) price target on shares of Spire Healthcare Group in a research note on Thursday, January 4th.

Spire Healthcare Group (LON SPI) traded down GBX 4.60 ($0.06) during midday trading on Friday, hitting GBX 249.20 ($3.38). 588,521 shares of the stock traded hands, compared to its average volume of 1,280,000. Spire Healthcare Group has a twelve month low of GBX 218.20 ($2.96) and a twelve month high of GBX 362.10 ($4.91). The stock has a market capitalization of $1,020.00 and a price-to-earnings ratio of 3,560.00.

In other Spire Healthcare Group news, insider Justin Ash bought 84,500 shares of the business’s stock in a transaction dated Thursday, November 23rd. The shares were acquired at an average cost of GBX 237 ($3.21) per share, with a total value of £200,265 ($271,582.59). Also, insider Peter R. Bamford bought 5,000 shares of the business’s stock in a transaction dated Monday, November 27th. The stock was acquired at an average cost of GBX 240 ($3.25) per share, for a total transaction of £12,000 ($16,273.39).

ILLEGAL ACTIVITY WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2018/01/19/spire-healthcare-group-plc-spi-receives-consensus-rating-of-hold-from-analysts.html.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply